LBF20207PG30: Difference between revisions
No edit summary |
No edit summary |
||
(12 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
|LipidBank=XPR1714 | |LipidBank=XPR1714 | ||
|LipidMaps=LMFA03010014 | |LipidMaps=LMFA03010014 | ||
|SysName=9- | |SysName=9-Oxo- (11alpha,15S,20) -trihydroxy-prosta- (cis-5,trans-13) -dien-1-oic acid | ||
|Common Name=&&20-hydroxy Prostaglandin E_2&&9- | |Common Name=&&20-hydroxy Prostaglandin E_2&&9-Oxo- (11alpha,15S,20) --trihydroxy-prosta- (5Z,13E) -dien-1-oic acid&& | ||
|Source=20-hydroxy PGE2 is a product of cytochrome P450 metabolism of PGE2.[[Reference:Oliw_EH:,Biochim. Biophys. Acta,1989,1001,107|{{RelationTable/GetFirstAuthor|Reference:Oliw_EH:,Biochim. Biophys. Acta,1989,1001,107}}]][[Reference:Oliw_EH:Fahlstadius_P:Hamberg_M:,J. Biol. Chem.,1986,261,9216|{{RelationTable/GetFirstAuthor|Reference:Oliw_EH:Fahlstadius_P:Hamberg_M:,J. Biol. Chem.,1986,261,9216}}]] | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} |
Latest revision as of 08:32, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1714 |
LipidMaps | LMFA03010014 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG30 |
20-hydroxy Prostaglandin E2 | |
---|---|
Structural Information | |
9-Oxo- (11α,15S,20) -trihydroxy-prosta- (cis-5,trans-13) -dien-1-oic acid | |
| |
Formula | C20H32O6 |
Exact Mass | 368.219888756 |
Average Mass | 368.46448 |
SMILES | C(CCC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)CO |
Physicochemical Information | |
20-hydroxy PGE2 is a product of cytochrome P450 metabolism of PGE2. Oliw_EH Oliw_EH et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|